- Home
- TPST vs ATCH Comparison
TPST vs ATCH Comparison
Compare TPST & ATCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TPST | ATCH |
|---|---|---|
| Founded | 2011 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9M | 46.0M |
| IPO Year | 2012 | 2024 |
Fundamental Metrics
Financial Performance| Metric | TPST | ATCH |
|---|---|---|
| Price | $2.07 | $0.29 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $11.00 | $1.00 |
| AVG Volume (30 Days) | 282.8K | ★ 4.0M |
| Earning Date | 05-08-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.06 |
| Revenue | ★ $295,000.00 | N/A |
| Revenue This Year | N/A | $84.47 |
| Revenue Next Year | N/A | $39.32 |
| P/E Ratio | ★ N/A | $4.97 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.50 | $0.14 |
| 52 Week High | $12.22 | $1.92 |
Technical Indicators
Market Signals| Indicator | TPST | ATCH |
|---|---|---|
| Relative Strength Index (RSI) | 55.52 | 60.06 |
| Support Level | $1.50 | $0.25 |
| Resistance Level | $2.48 | $0.33 |
| Average True Range (ATR) | 0.20 | 0.03 |
| MACD | 0.02 | 0.00 |
| Stochastic Oscillator | 49.39 | 59.78 |
Price Performance
Historical ComparisonAbout TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
About ATCH AtlasClear Holdings Inc.
AtlasClear Holdings Inc is a fintech company. Its goal is to build a cutting-edge technology-enabled financial services firm that would create a more efficient platform for trading, clearing, settlement, and banking of evolving and financial products with a focus on financial services firms. It is a fintech-driven business-to-business platform that expects to power innovation in fintech, investing, and trading. The company believes it is positioned to provide a modern, mission-critical suite of solutions to its clients, enabling them to reduce their transaction costs and compete more effectively in their businesses.